Europe Autoimmune Disease Diagnostics Market - Segmented by Disease Type, Diagnosis, and Geography - Growth, Trends, and Forecast (2018 - 2023)

  • ID: 4591825
  • Report
  • Region: Europe
  • 88 pages
  • Mordor Intelligence
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Biomérieux
  • Bio-rad Laboratories
  • F. Hoffmann-la Roche
  • Myriad Genetics
  • Novartis AG
  • MORE
The Europe autoimmune disease diagnostics market is expected to register a CAGR of 7.8%, during the forecast period, 2018 to 2023. Autoimmune diseases are a group of diseases characterized by inflammatory reactions caused by immune responses mistakenly generated against body tissues. The term autoimmune disease refers to a varied group of illnesses that involve almost every human organ system. Environmental, infectious, and genetic factors play an important role in initiating or exacerbating autoimmune diseases.

Partnerships with Physicians and Clinical Laboratories

Treatment of autoimmune diseases requires diagnosis of the disease at the onset of disease or later. This involves clinical laboratories checking for symptoms and providing the information to physician for better treatment of the disease. All the diagnostic laboratories do not have proper equipment for carrying out immunoassays. In that case, patient will face trouble in getting the tests done and then handing over the result to the physician. To overcome these problems, recently physicians and clinical laboratories started collaborating. Since, a physician knows where proper immunoassays and immunodiagnostics can be carried out, physician collaborates with that laboratory and suggests patient to get their tests done from there and the results will directly be sent to the physician. And, with increasing usage of Electronic Medical Records (EMR), labs have access to real-time test data and metrics extracted from the Laboratory Information System (LIS) and physicians too have access to these records, which increases efficiency in diagnosis, thus boosting autoimmune diagnostics market. The other factors, such as improved laboratory automation, growing public awareness of autoimmune disease, technological advancements, and expansion in coverage allowed by patient protection and affordable care act are driving the Europe autoimmune disease diagnostics market.

Slow Turnaround Time for Autoimmune Disease Diagnostic Test Results

Diagnosis of autoimmune diseases is a time consuming process. It involves procedures such as serum testing for diseases like rheumatoid arthritis, Addison’s disease, Hashimoto’s disease, and others. Testing protocols allow autoimmune disorders to be diagnosed in a highly efficient, cost effective manner. However, turnaround time for the test results is slow, owing to lesser automation techniques. It takes days to deliver all test results to the patients with proper explanation of false positive results. For example, autoimmune Lymph proliferative Syndrome is an autoimmune disease with turnaround time of up to 12 weeks; single gene sequencing takes 4 weeks. Therefore, this slow turnaround time is hindering the Europe autoimmune disease diagnostics market. The other factor, such as high frequency of false positive result is also hindering the growth of the market.

Germany Lead the Market in Europe Region

The Germany autoimmune disease diagnostics market holds the largest market share in 2017 in Europe region with a CAGR of over 7% due to the increasing healthcare expenditure and increasing prevalence of autoimmune diseases in this region.

Key Developments in the Market:
  • August 2017 - BioMérieux, received SERVICE 800 award in an annual conference held in Minneapolis
  • August 2017 - Thermo Fisher Scientific has acquired the Patheon, a leading contract development and manufacturing organization (CDMO) serving the pharmaceutical and biotechnology sectors
Major Players: F. HOFFMANN-LA ROCHE, SIEMENS HEALTHINEERS INC, BIOMÉRIEUX, NOVARTIS AG, THERMO FISHER SCIENTIFIC, MYRIAD GENETICS, ABBOTT LABORATORIES and BIO-RAD LABORATORIES, among others.

Reasons to Purchase this Report
  • Current and future Europe autoimmune disease diagnostics market outlook in the developed and emerging markets
  • Analyzing various perspectives of the market with the help of Porter’s five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness fastest growth during the forecast period
  • Identifying the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet (in excel)
Customization of the Report

This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Biomérieux
  • Bio-rad Laboratories
  • F. Hoffmann-la Roche
  • Myriad Genetics
  • Novartis AG
  • MORE
1. Introduction
1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Growing Public Awareness Of Autoimmune Disease
6.1.2 Improved Laboratory Automation
6.1.3 Partnerships With Physicians And Clinical Laboratories
6.1.4 Technological Advancements
6.1.5 Expansion In Coverage Allowed By Patient Protection And Affordable Care Act
6.2 Market Restraints
6.2.1 Slow Turnaround Time For Autoimmune Disease Diagnostic Test Results
6.2.2 High Frequency Of False Positive Result
6.3 Opportunities
6.4 Key Challenges

7. Market Segmentation
7.1 By Disease Type
7.1.1 Systemic Autoimmune Disease
7.1.1.1 Rheumatoid Arthritis
7.1.1.2 Psoriasis
7.1.1.3 Systemic Lupus Erythematosus (SLE)
7.1.1.4 Multiple Sclerosis
7.1.1.5 Others
7.1.2 Localized Autoimmune Disease
7.1.2.1 Inflammatory Bowel disease
7.1.2.2 Type 1 Diabetes
7.1.2.3 Thyroid
7.1.2.4 Others
7.2 By Diagnosis
7.2.1 Immunofluorescence assays (IFA)
7.2.2 Enzyme-linked Immunosorbent Assay (ELISA)
7.2.3 Western Blotting
7.2.4 Dot blot
7.2.5 Line blot
7.2.6 Multiplex Immunoassay
7.2.7 Agglutination
7.2.8 Double Immune Diffusion
7.2.9 Counter Immune-electrophoresis
7.2.10 Others
7.3 By Geography
7.3.1 Europe
7.3.1.1 France
7.3.1.2 Germany
7.3.1.3 United Kingdom
7.3.1.4 Italy
7.3.1.5 Spain
7.3.1.6 Rest Of Europe

8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches

9. Key Players
9.1 Abbott Laboratories
9.2 Biomérieux
9.3 Bio-rad Laboratories
9.4 F. Hoffmann-la Roche
9.5 Myriad Genetics
9.6 Novartis AG
9.7 Siemens Healthineers Inc
9.8 Thermo Fisher Scientific
*List Not Exhaustive

10. Future of the Market
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • F. Hoffmann-la Roche
  • Siemens Healthineers Inc
  • Biomérieux
  • Novartis AG
  • Thermo Fisher Scientific
  • Myriad Genetics
  • Abbott Laboratories
  • Bio-rad Laboratories
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll